$SENS

On CNBC’s “Mad Money Lightning Round,” Jim Cramer recommended buying Carpenter Technology (CRS) after it announced a $1 billion buyback and a 20 cents per share quarterly dividend. He called DXC Technology (DXC) a “value trap” after mixed Q2 results. He also commented on several other stocks including SENS, Ubiquiti (UI), Hess Midstream (HESM), Zeta Global, UL Solutions, and Coupang.

Senseonics Holdings, Inc. (SENS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sens-20260806xex99d1.htm EX-99.1 ​ Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results ● Generated second quarter revenue of $14.5 million, an increase of approximately 120% year-over-year ● Raising full-year 2026 revenue guidance to $62 million to $

Senseonics Holdings, Inc., a medical technology company focused on continuous glucose monitoring (CGM) systems, announced the successful closing of its $92 million public offering. The offering included common stock and pre-funded warrants, with the underwriters fully exercising their option to purchase additional shares. This capital raise will support the company's ongoing development and commercialization efforts for its implantable CGM devices.

Senseonics Holdings, Inc. announced the commencement of an underwritten public offering of its common stock and pre-funded warrants, aiming to raise $80 million. The company plans to use the net proceeds to fund the launch of Eversense 365, continue developing pipeline products, and for general corporate purposes. TD Cowen and Barclays are acting as joint book-running managers for the offering.

Senseonics Holdings, Inc. has filed a prospectus supplement for a primary offering of $80 million in common stock and pre-funded warrants. The company intends to use the net proceeds to fund the ongoing launch of its Eversense 365 system, continued pipeline product development, working capital, and general corporate purposes. Preliminary financial estimates for Q1 2026 include approximately $11.7 million in revenue and a net loss between $31 million and $33 million.

Edward Fiorentino, a director at Senseonics Holdings, Inc. (SENS), reported an acquisition of 2,124 shares of common stock on April 1, 2026. This grant, valued at $14,124.60 at a price of $6.65 per share, was compensation in lieu of quarterly cash retainer fees. Following this transaction, Fiorentino directly holds 73,487 shares of Senseonics common stock.

Senseonics (SENS) delivered earnings and revenue surprises of -30.30% and +1.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Senseonics Holdings, Inc. ( AMEX:SENS ) shares are trading lower on Tuesday after the company disclosed preliminary third-quarter FY25 results and a 1-for-20 reverse stock split on Monday.

CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at ...

Senseonics (SENS) delivered earnings and revenue surprises of 0.00% and +4.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?